PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
Polomar Health Services, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026
- Market cap
- $3.37M
- P/E (TTM)
- –
- Dividend yield
- –
Polomar Health Services statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Market Cap | $3.41M | $164.85M |
| Enterprise Value | $3.23M | $87.06M |
| PS Ratio | 1.07 | 3.60 |
Enterprise value
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| EV / Sales | 1.02 | 2.43 |
Income (trailing twelve months)
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Revenue | $3.17M | $57.94M |
| Gross Profit | $1.94M | $90.47M |
| Operating Income | -$9.36M | -$21.44M |
| Net Income | -$9.46M | -$22.46M |
| EBITDA | -$85.97K | -$16.91M |
| EPS (Diluted) | -$0.34 | -$0.83 |
Margins
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Gross Margin | 61.1% | 52.3% |
| Operating Margin | -295.0% | -44.5% |
| Profit Margin | -298.3% | -39.2% |
| EBITDA Margin | -2.71% | -31.3% |
Returns
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Return on Equity (ROE) | -257.9% | -53.1% |
| Return on Assets (ROA) | -184.7% | -41.0% |
| Return on Invested Capital (ROIC) | -206.7% | -32.0% |
Growth
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7688.8% | 6.01% |
| Revenue Growth (3Y CAGR) | 165.8% | 2.25% |
Balance sheet
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $178.87K | $62.42M |
| Net Cash (Debt) | $178.87K | $15.68M |
| Net Cash Per Share | $0.01 | $0.66 |
| Equity (Book Value) | -$1.06M | $48.79M |
| Book Value Per Share | -$0.04 | $1.36 |
| Tangible Book Value | -$1.06M | $23.06M |
Financial position
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Interest Coverage | -90.30 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.96K | -$12.35M |
Efficiency
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Asset Turnover | 0.62 | 0.38 |
| Inventory Turnover | 14.22 | 2.67 |
| Revenue Per Employee | $528.74K | $398.96K |
| Profits Per Employee | -$1.58M | -$703.34K |
| Employee Count | 6 | 74 |
Dividends and yields
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Earnings Yield | -277.9% | -22.7% |
Shares
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Shares Outstanding | 28,380,900 | 58,179,650 |
| Shares Change (YoY) | 1.06% | 11.1% |
| Shares Change (QoQ) | 0.81% | 0.54% |
| Float | 28,239,800 | 49,173,100 |
| Shares Held by Insiders | 0.50% | 11.6% |
Scores
| Measure | Polomar Health Services | Industry median |
|---|---|---|
| Altman Z-Score | -56.17 | -0.24 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | -123.93 | -2.62 |
Calculated by StockData from Polomar Health Services's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.